Folate-related genes and omphalocele

American Journal of Medical Genetics

Volumn 136 A, Issue 1, 2005, Pages 8-11

  Mills, James L ^a   Druschel, Charlotte M ^b   Pangilinan, Faith ^c   Pass, Kenneth ^d   Cox, Christopher ^a   Seltzer, Rebecca R ^c   Conley, Mary R ^a   Brody, Lawrence C ^c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WADSWORTH CENTER   (United States)

Author keywords

Birth defects; Folate; Folic acid; MTHFR, MTHFD1; Multivitamins; Omphalocele; Reduced folate carrier; Transcobalamin II; Ventral wall defects; Vitamins

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; ENZYME; FOLIC ACID; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; MULTIVITAMIN; REDUCED FOLATE CARRIER; THYMINE; TRANSCOBALAMIN II;

ADULT; ALLELE; ARTICLE; BIRTH DEFECT; CHILD; CLINICAL ARTICLE; CONCEPTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; GENE; HUMAN; MALE; MTHFD1 GENE; MTHFR GENE; NEURAL TUBE DEFECT; NUCLEIC ACID BASE SUBSTITUTION; OMPHALOCELE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLC19A1 GENE; TCN2 GENE;

ADULT; CASE-CONTROL STUDIES; DNA; FEMALE; FOLIC ACID; GENE FREQUENCY; GENOTYPE; HERNIA, UMBILICAL; HUMANS; INFANT, NEWBORN; MALE; MATERNAL AGE; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEW YORK; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECONCEPTION CARE; PREGNANCY; TRANSCOBALAMINS;

EID: 21644480407     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30772     Document Type: Article

References (20)

1. Afman LA, Lievers KJ, van der Put NM, Trijbels FJ, Blom HJ. 2002. Single nucleotide polymorphisms in the transcobalamin gene: Relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 10:433-438.
2. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol 151:862-877.
3. Botto LD, Mulinare J, Erickson JD. 2002. Occurrence of omphalocele in relation to maternal multivitamin use: A population-based study. Pediatrics 109:904-908.
4. Breslow N, Day NE. 1980. Statistical methods in cancer research volume 1: The analysis of case-control studies. Lyon: International Agency for Research on Cancer, Scientific publications No. 32.
5. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A, Scott JM, Swanson DA. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet 71:1207-1215.
6. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
7. De Marco P, Calevo MG, Moroni A, Merello E, Raso A, Finnell RH, Zhu H, Andreussi L, Cama A, Capra V. 2003. Reduced folate carrier polymorphism (80A→G) and neural tube defects. Eur J Hum Genet 11:245-252.
8. Honein MA, Paulozzi LJ. 1999. Birth defects surveillance: Assessing the "gold standard". Am J Public Health 89:1238-1240.
9. Kirke PN, Mills JL, Molloy AM, Brody LC, O'Leary VB, Daly L, Murray S, Conley M, Mayne PD, Smith O, Scott JM. 2004. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: Case-control study. Br Med J 328:1535-1536.
10. Morin I, Devlin AM, Leclerc D, Sabbaghian N, Halsted CH, Finnell R, Rozen R. 2003. Evaluation of genetic variants in the reduced folate carrier and in glutamate carboxypeptidase II for spina bifida risk. Mol Genet Metab 79:197-200.
11. MRC Vitamin Study Group. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet 338:131-137.
12. New York State Department of Health-Congenital Malformations Registry Annual Report. Statistical Summary of Children Born in 1996-97 and Diagnosed Through 1999-2002.
13. Pietrzyk JJ, Bik-Multanowski M. 2003. 776C→G polymorphism of the transcobalamin II gene as a risk factor for spina bifida. Mol Gen Metab 80:364.
14. Relton CL, Wilding CS, Pearce MS, Laffling AJ, Jonas PA, Lynch SA, Tawn EJ, Burn J. 2004. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41:256-260.
15. Salihu HM, Pierre-Louis BJ, Druschel CM, Kirby RS. 2003. Omphalocele and gastroschisis in the State of New York, 1992-1999 Birth Defects Res Part. A Clin Mol Teratol 67:630-636.
16. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. 2002. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108:1-6.
17. Stoll C, Alembik Y, Dott B, Roth MP. 2001. Risk factors in congenital abdominal wall defects (omphalocele and gastroschisis): A study in a series of 265,858 consecutive births. Ann Genet 44:201-208.
18. van der Put NM, Steegers-Theunissen RP, Frosst P, Trijbels FJ, Eskes TK, van den Heuvel LP, Mariman EC, den Heyer M, Rozen R, Blom HJ. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346:1070-1071.
19. Wacholder S, Rothman N, Caporaso N. 2002. Counterpoint: Bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11:513-520.
20. Whitehead AS, Gallagher P, Mills JL, Kirke PN, Burke H, Molloy AM, Weir DG, Shields DC, Scott JM. 1995. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88:763-766.